These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [The effects of preparations that influence the brain monoaminergic systems in pain syndromes]. Danilova EI; Grafova VN; Reshetniak VK Eksp Klin Farmakol; 1995; 58(4):14-7. PubMed ID: 7580744 [No Abstract] [Full Text] [Related]
45. Inhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level? Mei X; Wang W; Wang W; Li Y; Zhang H; Wu S; Li Y; Xu L J Neurochem; 2009 Jun; 109(6):1691-700. PubMed ID: 19383087 [TBL] [Abstract][Full Text] [Related]
47. Anti-inflammatory and analgesic activities of the aqueous extract of Acacia karroo stem bark in experimental animals. Adedapo AA; Sofidiya MO; Masika PJ; Afolayan AJ Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):397-400. PubMed ID: 18803636 [TBL] [Abstract][Full Text] [Related]
48. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. Cialdai C; Giuliani S; Valenti C; Tramontana M; Maggi CA J Pharmacol Exp Ther; 2009 Dec; 331(3):1025-32. PubMed ID: 19745108 [TBL] [Abstract][Full Text] [Related]
49. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo. Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781 [TBL] [Abstract][Full Text] [Related]
50. [Drug treatment of pain. 3: Properties of peripherally acting analgesics and rules for their prescription]. Kromer W Fortschr Med; 1986 Jun; 104(22):448-50. PubMed ID: 3744248 [No Abstract] [Full Text] [Related]
51. New horizons in pharmacologic treatment for rheumatic disease pain. Dray A Rheum Dis Clin North Am; 2008 May; 34(2):481-505. PubMed ID: 18638688 [TBL] [Abstract][Full Text] [Related]
52. [Importance of animal experiments in pain research and development of pain-deadening drugs]. Jurna I Arzneimittelforschung; 1981; Suppl 27():82-4. PubMed ID: 7197944 [No Abstract] [Full Text] [Related]
53. Pharmacogenetics in pain management: the clinical need. Webster LR Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063 [TBL] [Abstract][Full Text] [Related]
54. Combination therapy with flupirtine and opioid: studies in rat pain models. Goodchild CS; Kolosov A; Tucker AP; Cooke I Pain Med; 2008 Oct; 9(7):928-38. PubMed ID: 18950446 [TBL] [Abstract][Full Text] [Related]
56. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids. Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002 [TBL] [Abstract][Full Text] [Related]
57. Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Tong Y; Zhou XM; Wang SJ; Yang Y; Cao YL Arch Pharm Res; 2009 Apr; 32(4):527-33. PubMed ID: 19407970 [TBL] [Abstract][Full Text] [Related]
58. [Polycomponent analgetic drugs in the therapy of acute pain]. Nikoda VV; Maiachkin RB Ter Arkh; 2006; 78(1):73-6. PubMed ID: 16512451 [No Abstract] [Full Text] [Related]
59. Low-dose ketamine as an adjunct to routine pain practice: are we ready yet? Souzdalnitski D; Vadivelu N; Chung KS Pain Pract; 2009; 9(5):405-6. PubMed ID: 19740273 [No Abstract] [Full Text] [Related]
60. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Padi SS; Kulkarni SK Eur J Pharmacol; 2008 Dec; 601(1-3):79-87. PubMed ID: 18952075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]